Although drusen, Bruch's membrane and RPE changes are linked with SMD, these alterations could only be age-related mani festations and do not seem to be able by them selves to produce neovascularisation.4,24 It should be remembered that many eyes with drusen do not develop neovascular disciform lesions and that black32 and asiatic people33 rarely present with neovascular disciform degeneration.
Penetration of Bruch's membrane by choroidal blood vessels and proliferation of these vessels in the subpigment epithelial space is the essential change in disciform degeneration, as demonstrated by Gass.1 The factors that precipitate growth of these blood vessels have not yet been identified. It was thought for a long time that it was the origin of the new vessels that was important. There is now progressively more information available which suggests that environmental control is important in the growth of blood vessels, as shown by Patz34 and by Miller in experi mentally induced new vessels and RPE cell proliferation.35 Many other factors have been advocated: it has been suggested that closure of choroidal capillaries and intercapillary fibrosis may result in ischaemia of the outer retina and growth of new vessels.23,29 Disease of the retinal vascular supply has also been implicated as the cause of SMD,2 8 but the experimental work by Archer36 and Ryan3 7 demonstrated that retinal vascular occlusion is a minor factor in occurrence of SRNV.
Some additional stimuli have been pro posed for this vascular ingrowth. They include normaP8 or excessive39 exposure to light in a retina that may be deficient in ascorbates;29 photochemical damage to the membrane outer segments by free radicals that probably contributes to the accumulation of lipofuscin;31 inflammatory cells from the choroid such as macrophages that are known to collect beneath the RPE;40 and angiogenic factors.
It may also be possible that the neovascular response corresponds to a self defensive reac tion of the retina or to an attempt to eliminate toxic or waste products. In summary, blood vessel growth appears to be determined by a balance between inhibiting and stimulating influences.
It is significant that although the penetra tion of Bruch's membrane by choroidal blood vessels is histologically a widespread phe nomenon neovascular disciform lesion (as well as drusen and pigmentary changes) almost always occurs in the macular region. It is likely that production of disciform lesions is a peculiar property of the posterior fundus, dependent upon the unique anatomical and functional characteristics of that region: Firstly, there is little evidence to suggest that the choriocapillaris or Bruch's membrane is different centrally. Pigment epithelium cer tainly looks different in the fovea from elsewhere. Secondly, subretinal new vessels and recurrences occur mostly near the central avascular zone, at the border between vascu lar and avascular retina. Thirdly, it is the zone where luteal pigment is located in the inner layers of the retina. Finally, since the foveola is an all-cone retina and since the ganglion cell layer is much thicker at its border, the phago some material or the debris that is deposited on the inner surface of Bruch's membrane may be different.
Clinical Features
If only little is known about the mechanism of neovascularisation, we all recognise, as clini cians, that the risk of disciform degeneration is growth of the neovascular tissue and loss of central visual acuity. Once abnormal vessels proliferate they result in a detachment, per petuated by the constant transudation of plasma constituents, from the abnormal cap illaries into the subpigment epithelial space. The senile changes in the RPE, Bruch's mem brane and choroid allow widespread detach ment of the retinal pigment epithelium and serous or sero-sanguineous detachment of the neuro-sensory retina.
Symptoms caused by subretinal macular new vessels are related to anterior displace ment of the retina and to loss of retinal func tion. Anterior displacement of the retina causes blurred vision, distortion of lines, micropsia. Metamorphopsia which is best assessed by the Amsler grid is one of the earliest and most reliable symptoms and one of the most suggestive. Visual loss depends upon the location of new vessels, the extent of the retinal detachment and the degree of reti ' nal degeneration. A paracentral lesion may produce a scotoma near fixation but a major ity of patients will present with loss of central vision and particularly near vision. The speed of visual loss is variable. Though a few patients retain some macular function for a year or more, most progressively lose central vision within a year of onset of symptoms.
Clinical characteristics may indicate the presence of new vessels: namely, serous reti nal detachment, haemorrhages and lipids. I The serous retinal detachment is best seen with fundus biomicroscopy. It is usually shallow and increases on follow-up examin ation. It may be associated with a localised pigment epithelium detachment whose fluid may be clear or turbid. Cystoid retinal oedema may be visible, usually associated with long-standing detachment.
The neovascular tissue can rarely be identi fied by biomicroscopy. Only large draining vessels may be visible in advanced lesions. But the capillary network is difficult to distinguish. It can be suspected by localised retinal changes in an area which appears greyish and thickened. A ring of subretinal blood is usually present along the outer edge of the neovascular membrane.2 The most reliable indicator of a subretinal membrane is the presence of haemorrhage. The haemorrhage may be located beneath the pigment epi- progresses is also suggestive of neo vascularisation (Fig. 3) . The edge of tjIis detachment may retract, exposing the under lying Bruch's membrane. 43 On fluorescein angiography, this rip in the pigment epi thelium may mimic a neovascular lesion (Fig.  4) . Although neovascularisation and pigment epithelial tearing are both seen in the elderly, they may not always be directly related.
Natural history studies of subretinal macu lar new vessels growth have shown that they are the most dangerous component of senile macular degeneration. Their rapid growth is the turning point of the disease. and vitamins. None of them has proven to be effective yet randomised studies are in progress.
Laser photocoagulation is currently the only effective method to reduce the risk of severe visual loss in SMD. The early reports of photocoagulation in senile disciform macular degeneration showed poor visual results. With a better understanding of the disease process,1.2·3 a more rational approach to photocoagulation has evolved. This has given rise to better functional results. The random ised studies have shown that argon laser photocoagulation was effective in reducing the risk of legal blindness by more than 60 per cent in patients with a neovascular form of SMD.
Concerning laser treatment, I would limit myself to giving our present answers to the three main questions: Why? When? and How?
(1) Why? As already mentioned, the first question is answered: Laser treatment is useful and effi- results. In our experience, only 'hot-spots' are Fig. 6 (a) . The use of a transparent paper will allow the exact limits of the neovascular membrane to be delineated.
• Fig. 6 (b) . The precise location of the xanthophyllic area can also be drawn using the same transparent paper. Retrospective studies have been under taken to identify clinical features of the lesions amenable to photocoagulation and to deter- Fig. 6 (c) . Then it could be traced on the red-free or the colour print, finally to know the area to be treated and the area to be spared. The use of a transparent-paper will allow the exact limits of the neovascular membrane to be delineated. The precise location of the xanthophyllic area can also be drawn using the same transparent-paper and a blue-light print.49,So. Then it could be traced on the red free or on the colour print, finally to know very precisely the area to be treated and the area to be spared (Figs 6, a, b and c) . Treatment needs to be heavy and the photo coagulation lesions confluent or contiguous. 51 Intense and a relatively long duration appli cation of laser burns over the entire extent of the membrane is required. Usually, treatment is performed with a 200 micron spot-size and 0.5 second duration. The intensity must be sufficient to produce a uniformly white lesion, according to the circumstances and trans parency of the media. A topical anaesthesic only is used. Retrobulbar anaesthesia has been advocated to obtain better akinesia. But it does not avoid head movement and can cause unnecessary side-effects with persistant diplopia. We never use it.
The peripheral arcade must be treated initi ally, because bleeding could occur from this arcade. Test burns far from the centre will be useful to determine the correct level of inten sity. Immediately after this the peripheral arcade close to the fovea will be treated to avoid bleeding. The entire periphery of the membrane is then photocoagulated, extend ing 100 microns beyond the edge of the neo vascular complex. The central portion is treated with heavy overlapping burns. It is essential to treat the entire surface of the membrane to prevent post-operative bleeding and further extension of the membrane. If bleeding occurs during treatment, photo coagulation should be continued at the site of bleeding until it stops.
However, senile ocular media may induce difficulties for adequate treatment with con ventional argon laser because there is increased scattering of blue wavelength. Thus to obtain the delivery of equal energies per unit of area at the RPE level, one requires about four times as much blue light as red light. 52 Moreover, when new vessels are very near the centre of the fovea, there is considerable absorption of the blue wavelength at 488 nanometers by the xa.nthophyll pigment. In the human retina, macular luteal pigment can absorb more than 50 per cent of the argon blue light energy and can cause unnecessary damage in the inner layers of the retina. This intraretinal absorption creates a superficial white burn and will prevent delivery of energy to the subretinal tissues. It has been impli cated as a potential cause of post-operative foveal denervation. 53 The whitening of the inner layers will also obscure residual or recrudescent new vessels and make early retreatment difficult.
Recently, these difficulties have been over come by the development of monochromatic lasers. The efficiency of radiation depends on the transmission throughout ocular media and on the absorption by the target tissue. For parafoveolar photocoagulation, the ideal laser is one that emits a wavelength that is totally transmitted by ocular media, not absorbed by xanthophyll pigment and highly absorbed by melanine.
Several experimental and clinical studies with different lasers have been reported.54-{,() In our Department, we have evaluated the benefit of monochromatic green argon and red krypton lasers in clinical management. 59 Experiments were performed on eyes of adult baboons and histologic preparation for light and electron microscopy were obtained one hour and six weeks after applications of the burns.
Argon laser can be equipped with a filter to select only green wavelength (5 14.5 nm), with sufficient energy (Coherent 900). Histologic preparations after application of the burns showed sharply delimited lesions. Retinal pig ment epithelial cells were destroyed, especi ally at the edges of the burns. The inner layers of the retina were quite intact.
The krypton laser we used (900 K from Coherent) emits 80 per cent red light at 647.1 nm and 17 per cent yellow light at 518.1 nm. The absorption of the red light by luteal pig ment is about 1 per cent and the haemoglobin absorption is minimal. The histologic prep aration showed very sharply delimited lesions extending from the choriocapillaris to the outer layer but the inner layers were intact. At six weeks, the choriocapillaris was entirely obliterated and RPE proliferation partially filled the area of outer segments.
These histopathologic observations suggest that krypton red and green argon laser photo coagulation are both effective in closing choroidal vessels. Green argon had its maxi mum effect at the level of the retinal pigment epithelium. The krypton laser had its maxi-mum effect at the level of the choriocapillaris and the choroid. Krypton red photocoagula tion near the fovea results in less destruction of inner retina than argon-green but these effects may also be energy-dose related. 61 In our Department in Creteil, we studied the results of treatment of subretinal new vessels in senile macular degeneration per formed in 45 patients with green argon radia tion and in 85 patients with red krypton with at least one year of follow-up. We excluded from the study, 36 eyes treated for retrofoveolar new vessels growth. Patients were selected for treatment after meeting the following criteria: (1) visual acuity greater than or equal to 6/60 and (2) clinical and angiographic evidence of active sub retinal neovascuhirisation located 50 to 400 microns from the centre of the fovea.
All patients had a complete ophthalmic examination and a close follow-up. A photo graph in blue light was performed to locate the extent of the xanthophyll pigment. A photo graph in red light was taken to evaluate the status of the retinal pigment epithelium. A stereoscopic angiogram was done precisely to locate the neovascular membrane and the extent of associated haemorrhages.
In this prospective non-randomised study, either krypton or green laser were selected for the following types of cases: (1) a well-defined sub retinal neovascular net work extending into the foveal avascular zone; (2) a recurrence of new vessels on the foveal edge of a lesion previously treated with conventional argon laser; (3) a neovascular membrane located in the papillo-macular bundle. In addition, argon green laser was selected for cases with neovascular membranes that were very near the centre and lying upon the RPE and easily recognisable.
The krypton-red laser was selected for: (1) cases with subretinal new-vessels partially hidden by a turbid detachment of the RPE or the retina; (2) cases with a yellow lens (because red light is well transmitted in cloudy media); (3) neovascular membranes surrounded by a haemorrhagic border extending into the foveal avascular zone (red krypton radia tion is not absorbed by haemoglobine).
Effective treatment was defined as the absence of angiographic evidence of active and leaking subretinal neovascularisation, with a flat retina. Since January 1981, 130 patients with SMD and SRNV have been treated and followed for more than one year.
In the green argon-treated group (45 cases), mean initial visual acuity was 0.37. Closure of the new-vessels was achieved in 30 cases (66.6 per cent). Visual acuity was stabilised or improved in 26 cases. In 15 cases (33.3 per cent), it was not possible to prevent extension of the neovascular membrane into the foveola because of failure of patients to return in time for scheduled follow-up and because of insuf ficient treatment.
In the red-krypton treated group of patients (85 cases), mean initial visual acuity was 0.38, closure of the new-vessels was achieved in 51 cases (60 per cent); visual acuity was stabilised or improved in 35 cases. In 34 cases (40 per cent, it was not possible to prevent extension of the neovascular membrane into the foveola.
Choroidal bleeding is more frequent with krypton than with argon laser but has not so far induced functional damage in our cases. Heavy laser burns, particularly with krypton, induce delayed filling of the choriocapillaris which is transient and without symptoms. Absorption of the green wavelength by haemoglobin can induce damage to the retinal capillaries overlying these heavy confluent treatment sites. With krypton laser, the macu lar retinal capillaries in front of the burns remain patent and not leaky even on imme diate angiogram.
Red krypton and green argon laser offer a better alternative for treatment of neovascu lar membranes located near the foveola. The relative merits of the different lasers as thera peutic agents can be assessed only by the con trolled clinical trials now in process.
To obtain optimal results all patients have to adhere to a close follow-up schedule every 10 days during the first month, therafter every month for three months and later on twice a year. Functional, biomicroscopic and angiographic assessments have to be per formed at each visit: decrease in visual acuity, increase in metamorphopsia, and persistance or increase of retinal serous detachment are indications for immediate fluorescein angiography. It is also important to examine the fellow eye at each visit. Even in patients who are well informed and aware of their condition, a rapid enlargement of a subretinal neovascular membrane may threaten or destroy central vision.
The main complication of laser photo coagulation is incomplete or inadequate treat ment. Frequently, the vascular tissue is not completely obliterated by the initial laser ses sion. Surviving capillaries may exist within the lesion. The appearance of a grey-green or yellow-pink coloured elevation at the margin of the treatment area means a recurrence of neovascularisation, easily visible on the angiogram.51 If residual or recrudescent new vessels are detected, additional laser treat ment, if possible, will be performed until all blood vessels are obliterated, unless the foveola itself is involved.
Most of the recurrences occur at the edges of the treated area and particularly at the edge nearest the foveola. Close follow-up has shown that recurrences occur not only during the first weeks after treatment but also during the first year and even later on because photo coagulation does not modify the basic process.
Patients with new vessels under the centre of the fovea present a special problem: severe visual loss may result immediately from foveolar photocoag u lation. While obliterat ing a small subfoveal lesion could facilitate the use of low-vision aid by preserving more of the parafoveal retina, considerable caution is advisable for two reasons: (1) subfoveal mem branes do not have a uniformly poor prog nosis; (2) there are at present no data to document any benefit for treating subfoveal new vessels membrane. Two studies, at least, are in progress at the moment: in the USA, the 'Subfoveolar Study', and in Creteil, the 'Perifoveolar Study' (laser destruction of all the macular subretinal new-vessels, sparing only the foveal avascular zone, has been able to give some useful results). Nevertheless, the use of photocoagulation in patients with extensive exudation and haemorrhagic lesions centred in the macular area in an effort to reduce the surrounding detachment and size of the central scotoma is of questionable value.62• But some of these patients may be helped by the use of appropriate low vision aids.
Laser treatment for subretinal neo vascularisation in senile macular degenera tion seems to be helpful and efficient, if it is an early and complete treatment: ophthal mologists have now increased responsibilities in the management of senile macular degener ation: firstly, to recognise and treat the treat able form of SMD, secondly, to reduce the delay of referral and initial ophthalmologic consultation. Recently, Bressler et al. 63 devel oped data to suggest that the majority of sub foveal membranes begin outside the centre and with time extend to a subfoveal position. Thus, it seems likely that earlier evaluation of patients with symptoms could enable us to identify a higher proportion of eyes with extrafoveolar neovascularisation that is ame nable to treatment.
While photocoagulation is the only effec tive means of treatment, and improves the visual prognosis in respect of the original lesion, it is unlikely that it reduces the risk of other neovscular lesions arising in the same eye since SMD is a diffuse disease and neo vascularisation is multi focal.
A significant number of recurrences occur each year. The long-term results of our ran domised study on SMD, after five years,M have shown that 32 per cent of patients treated have had recurrences. After five years, 56 per cent of the treated eyes had retained useful central vision compared to only 7 per cent of the non-treated eyes.
Why neovascularisation and recurrences appear mostly in the macular area and par ticularly near the foveal avascular zone remains unknown. The answer to this ques tion could help to find an aetiological or even a preventative treatment instead of destroying a part of the central retina to save a part of the central vision.
